alprazolam has been researched along with Somatoform Disorders in 7 studies
Alprazolam: A triazolobenzodiazepine compound with antianxiety and sedative-hypnotic actions, that is efficacious in the treatment of PANIC DISORDERS, with or without AGORAPHOBIA, and in generalized ANXIETY DISORDERS. (From AMA Drug Evaluations Annual, 1994, p238)
alprazolam : A member of the class of triazolobenzodiazepines that is 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine carrying methyl, phenyl and chloro substituents at positions 1, 6 and 8 respectively. Alprazolam is only found in individuals that have taken this drug.
Somatoform Disorders: Disorders having the presence of physical symptoms that suggest a general medical condition but that are not fully explained by another medical condition, by the direct effects of a substance, or by another mental disorder. The MEDICALLY UNEXPLAINED SYMPTOMS must cause clinically significant distress or impairment in social, occupational, or other areas of functioning. In contrast to FACTITIOUS DISORDERS and MALINGERING, the physical symptoms are not under voluntary control. (APA, DSM-V)
Excerpt | Relevance | Reference |
---|---|---|
" During the second 2 weeks, they all took the same dosage of the extended release formulation." | 2.69 | Medication side effects in anxious patients: negative placebo responses? ( Alexander, PE; Coleman, BS; Dempsey, GM; Jones, W; Swiontek, AM; Uhlenhuth, EH, 1998) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 3 (42.86) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hlal, H | 1 |
Barrimi, M | 1 |
Kettani, N | 1 |
Rammouz, I | 1 |
Aalouane, R | 1 |
Petrić, D | 1 |
Peitl, MV | 1 |
Peitl, V | 1 |
Roberson-Nay, R | 1 |
Latendresse, SJ | 1 |
Kendler, KS | 1 |
Hofmann, M | 1 |
Vidoni, F | 1 |
Reddy, J | 1 |
Khanna, S | 1 |
Anand, U | 1 |
Banerjee, A | 1 |
Uhlenhuth, EH | 1 |
Alexander, PE | 1 |
Dempsey, GM | 1 |
Jones, W | 1 |
Coleman, BS | 1 |
Swiontek, AM | 1 |
Dollfus, S | 1 |
Petit, M | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
The Effectiveness of Psychopharmacological Intervention Versus Cognitive Behavioural Couple Therapy and Their Combination in Perinatal Distressed Couples: A Randomized Clinical Trial[NCT06001021] | 80 participants (Anticipated) | Interventional | 2023-08-15 | Not yet recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 trial available for alprazolam and Somatoform Disorders
Article | Year |
---|---|
Medication side effects in anxious patients: negative placebo responses?
Topics: Acute Disease; Adult; Alprazolam; Anxiety Disorders; Delayed-Action Preparations; Dose-Response Rela | 1998 |
6 other studies available for alprazolam and Somatoform Disorders
Article | Year |
---|---|
["Factitious disorder and skin picking: Clinical approach". A case report].
Topics: Alprazolam; Anxiety Disorders; Comorbidity; Diagnosis, Differential; Disruptive, Impulse Control, an | 2014 |
High doses alprazolam induced amenorrhoea and galactorrhoea.
Topics: Adult; Alprazolam; Amenorrhea; Anti-Anxiety Agents; Anxiety Disorders; Delayed-Action Preparations; | 2011 |
A latent class approach to the external validation of respiratory and non-respiratory panic subtypes.
Topics: Age of Onset; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents; Diagnostic and Statistical Man | 2012 |
[SSRI-induced akathesia].
Topics: Adjustment Disorders; Akathisia, Drug-Induced; Alprazolam; Anti-Anxiety Agents; Antidepressive Agent | 1996 |
Alprazolam-induced hypomania.
Topics: Adult; Alprazolam; Anxiety Disorders; Bipolar Disorder; Depressive Disorder; Female; Humans; Psychia | 1996 |
[Chemotherapy principles of severe somatic expressions of anxiety in adolescents].
Topics: Adolescent; Alprazolam; Anxiety; Female; Humans; Imipramine; Somatoform Disorders | 1988 |